Trial Profile
Prospective study to investigate meropenem serum levels in sepsis patients with and without renal replacement therapy - Mero-REPLACE
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2017
Price :
$35
*
At a glance
- Drugs Meropenem (Primary)
- Indications Bacterial infections; Sepsis
- Focus Pharmacokinetics
- Acronyms Mero-REPLACE
- 13 Aug 2013 New trial record